期刊文献+

保加利亚乳酸杆菌分解多种尿毒素的定向诱变 被引量:7

Directed mutagenesis of lactobacillus bulgaricus for decomposition of uremic toxins
下载PDF
导出
摘要 目的选育一株能分解多种尿毒素的益生菌为慢性肾衰的肠道细菌疗法提供新菌种。方法原始保加利亚乳酸杆菌先经尿毒症患者血清诱导培养,后用物理(紫外线)和化学(硫酸二乙酯)双重多次诱变方法对其进行诱变,以肌酐分解率为观察指标,筛选出具有高效分解肌酐的乳酸菌,测定其遗传稳定性并观察其对尿素氮、尿酸、血磷、甲状旁腺素、同型半胱氨酸的分解能力。结果从大量突变株中选育出一株高效分解尿毒素的菌株DUC3-17,其肌酐、尿素氮、尿酸、血磷、甲状旁腺素、同型半胱氨酸的分解率为17.23%,36.02%,9.84%,15.73%,78.26%,12.69%。经5次传代其分解力仍稳定。原始菌株不具有分解上述毒素的能力。结论运用尿毒症患者血清定向诱导后经硫酸二乙酯-紫外线复合诱变的方法,成功获得一株高效分解多种尿毒素的保加利亚乳酸工程菌,其尿毒素分解力能够稳定遗传。 Objective We aimed to obtain a strain of probiotics from lactobacillus bulgaricus capable to decompose uremic toxins, to provide a new strain of intestinal bacterium for the treatment of chronic renal failure. Method The original lactobacillus bulgaricus was induced by incubation in uremic patients' sera, and then repeatedly induced by physical (ultraviolet radiation) and chemical (diethyl sulfate) methods. We used the decomposition ability to creatinine as the index, to select the strains capable to efficiently decompose creatinine, and then to test their genetic stability and their decomposition abilities to urea, uric acid, serum phosphate, parathyroid hormone, and homocysteine. Result After the inductive and mutagenic treatments, we obtained a strain of DUC3-17. The decomposition rates of this strain for creatinine, urea nitrogen, uric ac- id, phosphorus, parathyroid hormone and homocysteine were 17.23%, 36.02%, 9.84%, 15.73%, 78.26%, and 12.69%, respectively. These abilities were stable after 5 passages. The original lactobacillus bulgaricus did not have these abilities. Conclusion We used directed induction and physical and chemical methods to lactoba- cillus bulgaricus, and obtained a mutant strain that has greater abilities to decompose uremic toxins and was genetically stable.
出处 《中国血液净化》 2014年第3期169-172,179,共5页 Chinese Journal of Blood Purification
基金 国家自然科学基金资助(81270853)
关键词 保加利亚乳酸杆菌 肌酐 慢性肾衰竭 尿毒症毒素 Lactobacillus bulgaricus Creatinine Chronic renal failure Uremic toxins
  • 相关文献

参考文献9

  • 1Liabeuf S,Drüeke TB,Massy ZA.Protein-bound uremic toxins:new insight from clinical studies[J].Toxins (Basel),2011,3:911-9.
  • 2Mandal A,Das K,Roy S,et al.In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats[J].J Nephrol,2013;26:228-36.
  • 3Friedman EA.Can the bowel substitute for the kidney in advanced renal failure[J] ?Curr Med Res Opin,2009,25:1913-1918.
  • 4Ranganathan N,Patel BG,Marczely J,et al.In vitro and in vivo assessement of intraintestinal bacteriotherapy in chronic kidney disease[J].Amercian Society of Artificial Internal Organs,2006,52.70-79.
  • 5Ranganathan N,Friedman EA,Tam P,et al.Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney diseasc:a 6-month pilot scale trial in Canada.5[J].Curr Med Res Opin,2009,25:1919-1930..
  • 6Zhang S,Li D,Tian K,Bai Y,et al.Development of a recombinant ureolytic Lactococcus Lactis for urea removal[J].Artif Cells Blood Substit Immobil Biotechnol,2009,37:227-34.
  • 7刘广桢,陈建华,王旻.尿酸酶产生菌的筛选、基因克隆及表达[J].中国药科大学学报,2005,36(5):464-467. 被引量:10
  • 8芦烨,梁金钟,施铜铃.多抗性保加利亚乳杆菌的诱变和筛选[J].乳业科学与技术,2010,33(1):6-10. 被引量:3
  • 9邓小丽,安海英,张海宏,李广宁,徐慧.磷霉素产生菌的定向诱变育种[J].生物技术,2009,19(4):26-28. 被引量:3

二级参考文献25

  • 1李志成,徐怀德,王敏,蒋爱民,方勇.嗜热链球菌和保加利亚乳杆菌增菌培养研究[J].西北农林科技大学学报(自然科学版),2002,30(z1):50-52. 被引量:16
  • 2吴宪忠,赵辉,吴国峰.乳酸菌在酸奶中的应用及研究进展[J].中国酿造,2007,26(1):1-4. 被引量:19
  • 3N. Itoh, A. Kusaka, T. Hirota, et al. Microbial production of antibiotic fosfomycln by a stereoselective epoxidation and its formation mechanism[J]. Appl Microbiol Biotechnol, 1995, 43: 394-401.
  • 4Kumar S, Parvathi A, Hemandez RL, et al. Identification of a novel UDP - N - acetylgucosamione enolpyruvyl transferase (MurA) horn Vibrio fischefi that confers high fosfomycin resistance in Escherichia coil[J]. Arch Microbiol, 2009 May, 191(5): 425-429.
  • 5Ryan D, Woodyer, Gongyong Li,et al. New insight into the mechanism of methyl transfer during the biosynthesis of fosfomycin[J]. Chemical Communication, 2007, 359-361.
  • 6Fuller R. Peobiotics in human medicine[J]. Gut, 1991, 32: 439-442.
  • 7Robinson R K. Therap euti c Properties of Fermented Milks[C]. New York: Elsevier App lied Science, 1991, 45-64.
  • 8Hunger W, Peitersen N. New technical aspects of the preparation of starter culture[J]. Bulletin IDF, 1992, 277: 17-21.
  • 9O'Donovan GA, Kearney CL, Ingraham JL. Mutants of Escherichia coli with high minimal temperatures of growth[J]. Journal of Bacteriology, 1965, 90(3): 611-615.
  • 10Gorini L, Kanfman H. Selecting bacterial mutants by the penicillin method[J]. Science, 1965, (131): 604-605.

共引文献13

同被引文献91

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部